Pure Global

Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss) - Trial NCT06420700

Access comprehensive clinical trial information for NCT06420700 through Pure Global AI's free database. This phase not specified trial is sponsored by True You Weight Loss and is currently Recruiting. The study focuses on Obesity. Target enrollment is 100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06420700
Recruiting
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT06420700
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Ablation Registry (Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty for Weight Loss)
A Multi-site, Prospective Registry of Patients Undergoing Combined Gastric Mucosal Ablation With Endoscopic Sleeve Gastroplasty at True You Weight Loss

Study Focus

Obesity

Combined gastric mucosal ablation with endoscopic sleeve gastroplasty

Observational

procedure

Sponsor & Location

True You Weight Loss

Atlanta,Cary, United States of America

Timeline & Enrollment

N/A

Jan 31, 2024

Jan 31, 2028

100 participants

Primary Outcome

Percent Change in Total Body Weight Loss (TBWL) from Baseline

Summary

The purpose of this study is to construct a multi-site, prospective registry to evaluate the
 clinical outcomes of patients who have undergone combined gastric mucosal ablation with
 endoscopic sleeve gastroplasty at True You Weight Loss.

ICD-10 Classifications

Obesity
Other obesity
Obesity, unspecified
Obesity due to excess calories
Obesity and other hyperalimentation

Data Source

ClinicalTrials.gov

NCT06420700

Non-Device Trial